APstem Therapeutics
PrivateLast Round
VC Round
Sep 7, 2023
Total Funding Raised
$4.3M
Company Overview
APstem Therapeutics operates in Healthcare & Life Sciences and is based in Fremont, California. Its latest recorded funding round was a VC Round in September 2023.
APstem Therapeutics is a biotechnology company that develops regenerative cell therapies based on its proprietary Guide-Integrated Adult Stem Cells (giaSCs) platform for the treatment of chronic and incurable diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
APstem Therapeutics Comparables
Compare APstem Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cytora Therapeutics | 77% | |
| Seraxis | 67% | |
| Sana Biotechnology | 65% |
For institutional investors. Book with your work email.
APstem Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 7, 2023 | ||||
| Seed | Sep 1, 2020 | ||||
| Seed | May 1, 2019 | ||||
| Seed | Jan 17, 2018 | ||||
| Accelerator | Jan 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
APstem Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartX | Seed, Accelerator |
| InnoSpring | Seed |
| Beyond Ventures | Seed |
| MFund | Seed |
| Oriza Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2017
Received funding from StartX.
For institutional investors. Book with your work email.
APstem Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about APstem Therapeutics's valuation, stock price, and market status.
Is APstem Therapeutics a public or private company?
APstem Therapeutics is a private company.
What is the current stock price of APstem Therapeutics?
APstem Therapeutics is a private company, so its shares have no public market price. Caplight tracks APstem Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is APstem Therapeutics worth (valuation)?
Valuation information for APstem Therapeutics is not publicly available.
Can I buy APstem Therapeutics stock?
APstem Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was APstem Therapeutics's last funding round?
APstem Therapeutics's most recent funding round was VC Round on September 7, 2023.
Who are the main investors in APstem Therapeutics?
Key investors in APstem Therapeutics include StartX.
Will APstem Therapeutics IPO soon?
No public IPO plans have been announced for APstem Therapeutics.
How can I track APstem Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in APstem Therapeutics's shares on secondary markets.